CHARACTERIZATION OF CD34+/CD38- ACUTE MYELOID-LEUKEMIA

被引：0
|
作者：
WORMANN, B
GROVE, D
UNTERHALT, M
TOEPKER, S
AUL, C
HEYLL, A
BUCHNER, T
TERSTAPPEN, LWMM
机构：
[1] UNIV HOSP GOTTINGEN,DEPT INTERNAL MED,GOTTINGEN,GERMANY
[2] UNIV HOSP MUNSTER,DEPT INTERNAL MED,MUNSTER,GERMANY
[3] UNIV HOSP DUSSELDORF,DEPT INTERNAL MED,DUSSELDORF,GERMANY
[4] BECTON DICKINSON IMMUNOCYTOMETRY SYST,SAN JOSE,CA
来源：
BLOOD | 1993年 / 82卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A121 / A121
页数：1
相关论文
共 50 条
  • [41] STAT5A regulates DNMT3A in CD34+/CD38- AML cells
    Takeuchi, Asako
    Nishioka, Chie
    Ikezoe, Takayuki
    Yang, Jing
    Yokoyama, Akihito
    LEUKEMIA RESEARCH, 2015, 39 (08) : 897 - 905
  • [42] Protein Nanomedicine Exerts Cytotoxicity toward CD34+ CD38- CD123+ Leukemic Stem Cells
    Chandran, Parwathy
    Pavithran, Keechilat
    Sidharthan, Neeraj
    Sasidharan, Abhilash
    Nair, Shantikumar
    Koyakutty, Manzoor
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2015, 1 (12): : 1194 - 1199
  • [43] HIGHLY PURIFIED CD34+/CD38+ AND CD34+/CD38-HEMATOPOIETIC CELL-POPULATIONS ARE POLYCLONAL AND PML-RAR-NEGATIVE IN ACUTE PROMYELOCYTIC LEUKEMIA (APL)
    TURHAN, AG
    LEMOINE, FM
    DEBERT, C
    BONNET, ML
    BAILLOU, C
    MACINTYRE, EA
    VARET, B
    BLOOD, 1993, 82 (10) : A251 - A251
  • [44] PREDOMINANCE OF FUNCTIONAL MULTIDRUG-RESISTANCE (MDR-1) PHENOTYPE IN CD34+ ACUTE MYELOID-LEUKEMIA CELLS
    TEBOEKHORST, PAW
    DELEEUW, K
    SCHOESTER, M
    WITTEBOL, S
    NOOTER, K
    HAGEMEIJER, A
    LOWENBERG, B
    SONNEVELD, P
    BLOOD, 1993, 82 (10) : 3157 - 3162
  • [45] ISOLATION AND CHARACTERIZATION OF THE CD34+ HEMATOPOIETIC PROGENITOR CELLS FROM THE PERIPHERAL-BLOOD OF PATIENTS WITH CHRONIC MYELOID-LEUKEMIA
    SILVESTRI, FF
    BANAVALI, SD
    HULETTE, BC
    CIVIN, CI
    PREISLER, HD
    INTERNATIONAL JOURNAL OF CELL CLONING, 1991, 9 (05): : 474 - 490
  • [46] Expression of the target receptor CD33 on CD34+/CD38-/CD123+AML stem cells.
    Hauswirth, AW
    Florian, S
    Krauth, MT
    Printz, D
    Fritsch, G
    Sotlar, K
    Schernthaner, GH
    Wacheck, V
    Selzer, E
    Sperr, WR
    Valent, P
    BLOOD, 2003, 102 (11) : 249B - 250B
  • [47] Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities
    Costello, RT
    Mallet, F
    Gaugler, B
    Sainty, D
    Arnoulet, C
    Gastaut, JA
    Olive, D
    CANCER RESEARCH, 2000, 60 (16) : 4403 - 4411
  • [48] Novel Dicarboximide BK124.1 Breaks Multidrug Resistance and Shows Anticancer Efficacy in Chronic Myeloid Leukemia Preclinical Models and Patients' CD34+/CD38- Leukemia Stem Cells
    Stukan, Iga
    Gryzik, Marek
    Hoser, Grazyna
    Want, Andrew
    Grabowska-Pyrzewicz, Wioleta
    Zdioruk, Mikolaj
    Napiorkowska, Mariola
    Cieslak, Marcin
    Krolewska-Golinska, Karolina
    Nawrot, Barbara
    Basak, Grzegorz
    Wojda, Urszula
    CANCERS, 2022, 14 (15)
  • [49] Prognostic impact of the CD34+/CD38-cell burden in patients with acute myeloid leukemia receiving allogeneic stem cell transplantation
    Jentzsch, Madlen
    Bill, Marius
    Nicolet, Deedra
    Leiblein, Sabine
    Schubert, Karoline
    Pless, Martina
    Bergmann, Ulrike
    Wildenberger, Kathrin
    Schuhmann, Luba
    Cross, Michael
    Poenisch, Wolfram
    Franke, Georg-Nikolaus
    Vucinic, Vladan
    Lange, Thoralf
    Behre, Gerhard
    Mrozek, Krzysztof
    Bloomfield, Clara D.
    Niederwieser, Dietger
    Schwind, Sebastian
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (04) : 388 - 396
  • [50] Aclinically relevant population of leukemic CD34+CD38- cells in acute myeloid leukemia
    Gerber, Jonathan M.
    Smith, B. Douglas
    Ngwang, Brownhilda
    Zhang, Hao
    Vala, Milada S.
    Morsberger, Laura
    Galkin, Steven
    Collector, Michael I.
    Perkins, Brandy
    Levis, Mark J.
    Griffin, Constance A.
    Sharkis, Saul J.
    Borowitz, Michael J.
    Karp, Judith E.
    Jones, Richard J.
    BLOOD, 2012, 119 (15) : 3571 - 3577
12345